Skip to main content
TipRanks
Go Ultimate75% OFF

Artiva Biotherapeutics, Inc. (ARTV) Stock Forecast & Price Target

490 Followers
See the Price Targets and Ratings of:

ARTV Analyst Ratings

Hold
5Ratings
1Buy4Hold0Sell
Based on 5 analysts giving stock ratings to Artiva Biotherapeutics, Inc. in the past 3 months

ARTV Stock 12 Month Forecast

$14.33▲(274.24% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Artiva Biotherapeutics, Inc. in the last 3 months. The average price target is $14.33 with a high forecast of $35.00 and a low forecast of $4.00. The average price target represents a 274.24% change from the last price of $3.83.
Highest Price Target$35.00Average Price Target$14.33Lowest Price Target$4.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for ARTV
Price TargetArticle
Jefferies$23→$4hold4.44%UpsideDowngraded10/28/26
TD Cowen―hold―Downgraded10/27/26
Wedbush$4hold4.44%UpsideDowngraded10/27/26
Needham―hold―Downgraded10/27/26
H.C. Wainwright$35buy813.84%UpsideReiterated10/01/26
Cantor Fitzgerald$40buy944.39%UpsideReiterated05/25/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PALIPalisade Bio
RZLTRezolute
MDWDMediwound
OVIDOvid Therapeutics
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Artiva Biotherapeutics, Inc.

3 Months
Emily Bodnar
Emily BodnarH.C. Wainwright
Success Rate8/12 ratings generated profit
67%
Average Return
+20.67%

Copying Emily Bodnar's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +20.67% per trade.

1 Year
Joshua Schimmer
Joshua SchimmerCantor Fitzgerald
Success Rate3/6 ratings generated profit
50%
Average Return
+30.55%

Copying Joshua Schimmer's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +30.55% per trade.

2 Years
Joshua Schimmer
Joshua SchimmerCantor Fitzgerald
Success Rate3/6 ratings generated profit
50%
Average Return
-7.63%

Copying Joshua Schimmer's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -7.63% per trade.

ARTV Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ARTV
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy104353
Buy11110
Hold00044
Sell00000
Strong Sell00000
total1154107

In the current month, ARTV has received 3 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. ARTV average Analyst price target in the past 3 months is 14.33.

ARTV Financial Forecast

ARTV Stock Forecast FAQ

What is ARTV’s average 12-month price target, according to analysts?
Based on analyst ratings, Artiva Biotherapeutics, Inc.’s 12-month average price target is $14.33.
What is ARTV’s upside potential, based on the analysts’ average price target?
Artiva Biotherapeutics, Inc. has 274.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARTV a Buy, Sell or Hold?
Artiva Biotherapeutics, Inc. has a consensus rating of Hold which is based on 1 buy ratings, 4 hold ratings and 0 sell ratings.
What is Artiva Biotherapeutics, Inc.’s price target?
The average price target for Artiva Biotherapeutics, Inc. is $14.33. This is based on 5 12-month price targets, issued in the past 3 months. The highest analyst price target is $35.00, the lowest forecast is $4.00. The average price target represents a 274.24% increase from the current price of $3.83.
What do analysts say about Artiva Biotherapeutics, Inc.?
Artiva Biotherapeutics, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of ARTV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.